+Susen Rogen

Wednesday, 20 November 2013

Gabon Pharmaceuticals and Healthcare Report Q1 2014:Life Sciences Market Research Reports

Life Sciences Market Research Reports
 
Start taking a college level music theory class today.

This beginner class is now accessible to aspiring musicians of all ages. Learn all of the basic concepts in an easy to follow manner.
From our sponsors
Gabon Pharmaceuticals and Healthcare Report Q1 2014
Nov 20th 2013, 00:00, by vyankatesh

BMI View: Oil production in the country is stagnating. Despite government efforts to increase revenues from the mining sector, BMI predicts that a combination of faltering production and relatively subdued oil prices will prevent government revenues from rising in the face of booming public expenditure. We expect Gabon’s fiscal position to steadily decline, with the deficit expanding to 2.8% of GDP in 2018 – posing a high risk to public expenditure on improving access to healthcare services. Headline Expenditure Forecasts ? Pharmaceuticals: XAF67.65bn (US$136mn) in 2012 to XAF71.85bn (US$147mn) in 2013; +6.2% in local currency and +8.1% in US dollar …

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131591.

Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/gabon-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment